Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma

BACKGROUND: There are limited treatment options available for patients with advanced pancreatic ductal adenocarcinoma (PDAC). We conducted a phase II study evaluating the efficacy and safety of capecitabine/oxaliplatin (CAPOX) in patients with locally advanced and metastatic PDAC treated in the firs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Gastrointest Oncol
Autores principales: Bullock, Andrea, Stuart, Keith, Jacobus, Susanna, Abrams, Thomas, Wadlow, Raymond, Goldstein, Michael, Miksad, Rebecca
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2017
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750180/
https://ncbi.nlm.nih.gov/pubmed/29299353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.06
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares